Long-term neurological outcomes in West Nile virus-infected patients: An observational study

American Journal of Tropical Medicine and Hygiene

Volumn 92, Issue 5, 2015, Pages 1006-1012

  Weatherhead, Jill E ^a   Miller, Vicki E ^b   Garcia, Melissa N ^a   Hasbun, Rodrigo ^b   Salazar, Lucrecia ^b   Dimachkie, Mazen M ^c   Murray, Kristy O ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ARTICLE; BABINSKI REFLEX; BRAIN FUNCTION; COMORBIDITY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; ENCEPHALITIS; FEMALE; FOLLOW UP; HEALTH SURVEY; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENTAL HEALTH; MOTOR PERFORMANCE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROLOGIC GAIT DISORDER; NEUROLOGICAL COMPLICATION; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATHOLOGICAL REFLEX; RISK FACTOR; VIBRATION SENSE; VISUAL ACUITY; WEST NILE ENCEPHALITIS; WEST NILE FEVER; WEST NILE MENINGITIS; WEST NILE VIRUS; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; DEMOGRAPHY; LONGITUDINAL STUDY; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; YOUNG ADULT;

WEST NILE VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMOGRAPHY; ENCEPHALITIS, VIRAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENINGITIS, VIRAL; MIDDLE AGED; NERVOUS SYSTEM DISEASES; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 84929093536     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0616     Document Type: Article

References (18)

1. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, Huang A, 2001. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344: 1807-1814.
2. Centers for Disease Control and Prevention, 2006. Assessing the capacity for surveillance, prevention, and control of West Nile virus infection-United States, 1999-2004. MMWR 55: 150-153.
3. Lillibridge K, Parsons R, Randle Y, Travassos da Rosa AP, Guzman H, Siirin M, Wuithiranyagool T, Hailey C, Higgs S, Bala AA, Pascua R, Meyer T, Vanlandingham DL, Tesh RB, 2004. The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg 70: 676-681.
4. Centers for Disease Control and Prevention, 2013. West Nile virus and other arboviral diseases-United States, 2012. MMWR 62: 513-517.
5. Craven RB, Roehrig JT, 2001. West Nile virus. JAMA 286: 651-653.
6. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, Katz N, Liljebjelke KA, Biggerstaff BJ, Fine AD, Layton MC, Mullin SM, Johnson AJ, Martin DA, Hayes EB, Campbell GL, 2001. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepide-miological survey. Lancet 358: 261-264.
7. Hayes EB, 2005. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11: 1174-1179.
8. Racsa L, Gander R, Chung W, Southern P, Le J, Beal S, Lee F, Cavuoti D, Reisch J, Alatoom A, 2014. Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. Diagn Microbiol Infect Dis 78: 132-136.
9. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI, 2004. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 141: 360-365.
10. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR, 2003. Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511-515.
11. Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD, 2004. West Nile virus: where are we now? Lancet Infect Dis 4: 547-556.
12. Roehrig JT, 2013. West Nile virus in the United States - a historical perspective. Viruses 10: 3088-3108.
13. Sejvar JJ, 2007. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 44: 1617-1624.
14. Klee AL, Maldin B, Edwin B, Poshni I, Motashari F, Fine A, Layton M, Nash D, 2004. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 1405-1411.
15. Tyler KL, 2004. West Nile virus infection in the United States. Arch Neurol 61: 1190-1195.
16. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, Cain K, Shallenberger R, York TL, Martinez D, Hellums JS, Hellums D, Malkoff M, Elgawley N, McNeely W, Khuwaja SA, Tesh RB, 2006. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 134: 1325-1332.
17. Anastasiadou A, Kakoulidis I, Butel D, Kehagia E, Papa A, 2013. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis 17: e494-e497.
18. Skoldenberg B, Aurelius E, Hjalmarsson A, Sabri F, Forsgren M, Andersson B, Linde A, Strannegård O, Studahl M, Hagberg L, Rosengren L, 2006. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol 253: 163-170.